Literature DB >> 7722420

Effects of endotoxin on expression of VLA integrins by human bronchoalveolar lavage macrophages.

Y H Kang1, C H Lee, S E Brummel, H H Newball, J Forrester.   

Abstract

Endotoxin (lipopolysaccharide, LPS) is known to induce inflammatory responses, such as monocyte/macrophage adherence, migration, and accumulation. Recruitment and accumulation of macrophages during infection and inflammation are regulated by integrin-mediated cell-extracellular matrix interactions. In the present report, we studied the effects of LPS on the expression of VLA-5 (alpha 5 beta 1), VLA-3 (alpha 3 beta 1), and VLA-2 (alpha 2 beta 1) integrins and fibronectin (FN) by human alveolar macrophages in an attempt to understand the mechanism by which LPS regulates macrophage adhesion to matrix proteins. Bronchoalveolar lavage macrophages were treated with varying concentrations of Escherichia coli LPS for different times and evaluated for expression of the integrins and FN by immunofluorescence, immunoelectron microscopy, autoradiography, and radioimmunoassay. Immunofluorescent and immunoelectron microscopic observations showed that VLA integrins were constitutively expressed on the cell surface and concentrated on the microvilli and pseudopodia of the macrophages. The effects of LPS on expression of the integrins were dose and time related. VLA-5 expression was increased after 30 min of stimulation by LPS, suggesting that LPS may induce rapid secretion of the integrin. However, incubations with LPS longer than 30 min decreased VLA-5 expression in a dose-dependent pattern. LPS also caused dose-related decreases in the expression of VLA-3 and VLA-2 integrins and increases of intracellular FN 24 h after stimulation. The results suggest that a prolonged exposure to LPS may impede VLA integrin-mediated migration and result in local accumulation of macrophages in the lung.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7722420     DOI: 10.1002/jlb.57.4.624

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  8 in total

Review 1.  Extracellular matrix and lung inflammation.

Authors:  J Roman
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

2.  Fetal bovine serum xenoproteins modulate human monocyte adhesion and protein release on biomaterials in vitro.

Authors:  David Schmidt; Evan James Joyce; Weiyuan John Kao
Journal:  Acta Biomater       Date:  2010-09-15       Impact factor: 8.947

3.  Integrin expression on neutrophils in a rabbit model of Group B Streptococcal meningitis.

Authors:  M E Rowin; V Xue; J Irazuzta
Journal:  Inflammation       Date:  2000-04       Impact factor: 4.092

4.  CCR8 signaling influences Toll-like receptor 4 responses in human macrophages in inflammatory diseases.

Authors:  Martina Kvist Reimer; Charlotte Brange; Alexander Rosendahl
Journal:  Clin Vaccine Immunol       Date:  2011-10-05

5.  Effect of inhaled endotoxin on induced sputum in normal, atopic, and atopic asthmatic subjects.

Authors:  J A Nightingale; D F Rogers; L A Hart; S A Kharitonov; K F Chung; P J Barnes
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

6.  Absence of the macrophage mannose receptor in mice does not increase susceptibility to Pneumocystis carinii infection in vivo.

Authors:  Steve D Swain; Sena J Lee; Michel C Nussenzweig; Allen G Harmsen
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

7.  Evaluation of endothelial cell integrins after in \ vitro contact with polyethylene terephthalate.

Authors:  E Cenni; D Granchi; E Verri; G Remiddi; D Cavedagna; A Di Leo
Journal:  J Mater Sci Mater Med       Date:  2001-04       Impact factor: 3.896

8.  Paired Ig-Like Type 2 Receptor-Derived Agonist Ligands Ameliorate Inflammatory Reactions by Downregulating β1 Integrin Activity.

Authors:  Kyoung-Jin Lee; Dongyoung Lim; Yeon Ho Yoo; Eun-Ji Park; Sun-Hee Lee; Birendra Kumar Yadav; Yong-Ki Lee; Jeong Hyun Park; Daejoong Kim; Kyeong Han Park; Jang-Hee Hahn
Journal:  Mol Cells       Date:  2016-06-15       Impact factor: 5.034

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.